Analyses of biopsy specimens from OSCC patients revealed that the BRD4 and MMP2 expression levels were correlated in the cancerous regions, and both were highly expressed in lymph node metastasis cases, including delayed metastasis. This evidence concerns the gene BRD4 and metastatic malignant neoplasm in the lymph nodes.